Drug Profile
Goserelin depot - GP Pharm
Latest Information Update: 29 Aug 2023
Price :
$50
*
At a glance
- Originator GP Pharm
- Class Antineoplastics; Infertility therapies; Oligopeptides; Pituitary hormone releasing hormones
- Mechanism of Action Gonadotropin releasing hormone stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Cancer; Endometriosis
Most Recent Events
- 29 Aug 2023 Discontinued - Preclinical for Cancer in Spain (PO) (GP Pharm website, August 2023)
- 29 Aug 2023 Discontinued - Preclinical for Endometriosis in Spain (PO) (GP Pharm website, August 2023)
- 28 Feb 2020 No recent reports of development identified for preclinical development in Cancer in Spain (PO, Controlled release)